143 related articles for article (PubMed ID: 12799552)
21. Utility of total lymphocyte count as a surrogate marker for CD4 counts in HIV-1 infected children in Kenya.
Githinji N; Maleche-Obimbo E; Nderitu M; Wamalwa DC; Mbori-Ngacha D
BMC Infect Dis; 2011 Sep; 11():259. PubMed ID: 21961890
[TBL] [Abstract][Full Text] [Related]
22. Pneumocystis jirovecii prophylaxis discontinuation based upon total lymphocyte count in HIV-infected adults treated with antiretroviral therapy.
Cheung C; Shuter J
Int J STD AIDS; 2010 Jun; 21(6):406-9. PubMed ID: 20606220
[TBL] [Abstract][Full Text] [Related]
23. Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus-infected patients who achieve durable virologic suppression: longer follow-up of an observational cohort study.
Sterling TR; Chaisson RE; Keruly J; Moore RD
J Infect Dis; 2003 Dec; 188(11):1659-65. PubMed ID: 14639536
[TBL] [Abstract][Full Text] [Related]
24. Relationship between total lymphocyte count (TLC) and CD4 count among peoples living with HIV, Southern Ethiopia: a retrospective evaluation.
Daka D; Loha E
AIDS Res Ther; 2008 Dec; 5():26. PubMed ID: 19102769
[TBL] [Abstract][Full Text] [Related]
25. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
[TBL] [Abstract][Full Text] [Related]
26. Rapid declines in total lymphocyte counts and hemoglobin concentration prior to AIDS among HIV-1-infected men.
Lau B; Gange SJ; Phair JP; Riddler SA; Detels R; Margolick JB
AIDS; 2003 Sep; 17(14):2035-44. PubMed ID: 14502006
[TBL] [Abstract][Full Text] [Related]
27. The role of non-viral load surrogate markers in HIV-positive patient monitoring during antiviral treatment.
Florence E; Dreezen C; Schrooten W; Van Esbroeck M; Kestens L; Fransen K; De Roo A; Colebunders R
Int J STD AIDS; 2004 Aug; 15(8):538-42. PubMed ID: 15307965
[TBL] [Abstract][Full Text] [Related]
28. Change in T-lymphocyte count after initiation of highly active antiretroviral therapy in HIV-infected patients with history of Mycobacterium avium complex infection.
Lazaro E; Coureau G; Guedj J; Blanco P; Pellegrin I; Commenges D; Dabis F; Moreau JF; Pellegrin JL; Thiébaut R;
Antivir Ther; 2006; 11(3):343-50. PubMed ID: 16759051
[TBL] [Abstract][Full Text] [Related]
29. Criteria for initiating highly active antiretroviral therapy and short-term immune response among HIV-1-infected patients in Côte d'Ivoire.
Diabaté S; Alary M
HIV Med; 2009 Nov; 10(10):640-6. PubMed ID: 19659945
[TBL] [Abstract][Full Text] [Related]
30. Monitoring antiretroviral therapy in HIV/AIDS patients in resource-limited settings: CD4 counts or total lymphocyte counts?
Mbanya D; Assah F; Ndembi N; Kaptue L
Int J Infect Dis; 2007 Mar; 11(2):157-60. PubMed ID: 16762583
[TBL] [Abstract][Full Text] [Related]
31. Initiation of highly active antiretroviral therapy in advanced AIDS with CD4 < 50 cells/mm3 in a resource-limited setting: efficacy and tolerability.
Sungkanuparph S; Kiertiburanakul S; Manosuthi W; Kiatatchasai W; Vibhagool A
Int J STD AIDS; 2005 Mar; 16(3):243-6. PubMed ID: 15829026
[TBL] [Abstract][Full Text] [Related]
32. Complete blood cell count as a surrogate CD4 cell marker for HIV monitoring in resource-limited settings.
Chen RY; Westfall AO; Hardin JM; Miller-Hardwick C; Stringer JS; Raper JL; Vermund SH; Gotuzzo E; Allison J; Saag MS
J Acquir Immune Defic Syndr; 2007 Apr; 44(5):525-30. PubMed ID: 17259910
[TBL] [Abstract][Full Text] [Related]
33. Total lymphocyte count of 1200 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala, Uganda.
Kamya MR; Semitala FC; Quinn TC; Ronald A; Njama-Meya D; Mayanja-Kizza H; Katabira ET; Spacek LA
Afr Health Sci; 2004 Aug; 4(2):94-101. PubMed ID: 15477187
[TBL] [Abstract][Full Text] [Related]
34. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy.
Smith CJ; Sabin CA; Youle MS; Kinloch-de Loes S; Lampe FC; Madge S; Cropley I; Johnson MA; Phillips AN
J Infect Dis; 2004 Nov; 190(10):1860-8. PubMed ID: 15499544
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of affordable screening markers to detect CD4+ T-cell counts below 200 cells/mul among HIV-1-infected Ugandan adults.
Miiro G; Nakubulwa S; Watera C; Munderi P; Floyd S; Grosskurth H
Trop Med Int Health; 2010 Apr; 15(4):396-404. PubMed ID: 20180936
[TBL] [Abstract][Full Text] [Related]
36. Evaluating total lymphocyte count as a surrogate marker for CD4 cell count in the management of HIV-infected patients in resource-limited settings: a study from China.
Chen J; Li W; Huang X; Guo C; Zou R; Yang Q; Zhang H; Zhang T; Chen H; Wu H
PLoS One; 2013; 8(7):e69704. PubMed ID: 23874985
[TBL] [Abstract][Full Text] [Related]
37. CD4 lymphocyte percentage predicts disease progression in HIV-infected patients initiating highly active antiretroviral therapy with CD4 lymphocyte counts >350 lymphocytes/mm3.
Hulgan T; Raffanti S; Kheshti A; Blackwell RB; Rebeiro PF; Barkanic G; Ritz B; Sterling TR
J Infect Dis; 2005 Sep; 192(6):950-7. PubMed ID: 16107946
[TBL] [Abstract][Full Text] [Related]
38. Total lymphocyte count and World Health Organization pediatric clinical stage as markers to assess need to initiate antiretroviral therapy among human immunodeficiency virus-infected children in Moshi, Northern Tanzania.
Johnson OO; Benjamin DK; Benjamin DK; Schimana W; Tillekeratne LG; Crump JA; Landman KZ; Kinabo GD; Mmbaga B; Msuya LJ; Shao JF; Swai ME; Cunningham CK
Pediatr Infect Dis J; 2009 Jun; 28(6):493-7. PubMed ID: 19436238
[TBL] [Abstract][Full Text] [Related]
39. The potential for CD4 cell increases in HIV-positive individuals who control viraemia with highly active antiretroviral therapy.
Smith CJ; Sabin CA; Lampe FC; Kinloch-de-Loes S; Gumley H; Carroll A; Prinz B; Youle M; Johnson MA; Phillips AN
AIDS; 2003 May; 17(7):963-9. PubMed ID: 12700445
[TBL] [Abstract][Full Text] [Related]
40. Total lymphocyte count is a reliable surrogate marker for CD4 cell counts after the first year of antiretroviral therapy: data from an Indonesian cohort study.
de Jong MA; Wisaksana R; Meijerink H; Indrati A; van de Ven AJ; Alisjahbana B; van Crevel R
Trop Med Int Health; 2012 May; 17(5):581-3. PubMed ID: 22364582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
